日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

EU backs AstraZeneca COVID-19 vaccine as blood clot reviews continue

Updated: 2021-04-24 05:47
Share
Share - WeChat
[Photo/Agencies]

April 23 - Europe's drug regulator reiterated on Friday the benefits of AstraZeneca's COVID-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determine the shot's use.

The renewed backing comes after several countries in the European Union and worldwide have limited the use of the vaccine, known as Vaxzevria. Denmark has stopped its use altogether, after possible links to clotting issues in combination with low platelet levels were confirmed.

The interim analysis by a committee of the European Medicines Agency (EMA) determined that serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, the regulator said in a statement.

EMA officials said in a briefing the update on Friday was aimed at putting into context the data it has collected and analysed to help 27 EU member states work out how to use the shot based on their local situations.

The advantages of getting the vaccine increase with age and with any rise in infections rates, but the benefits were for now evident across all scenarios and ages, the officials said.

They said the recommendation may be subject to change because more data is being collected, and for instance not all EU member states had included the sex of the vaccine recipients in their data.

But Peter Arlett, head of EMA's data analytics and methods task force, said: "The benefit risk balance of the AstraZeneca vaccine is positive. It's preventing serious disease and saving lives."

Earlier this month, the EMA said it had found a possible link between AstraZeneca's coronavirus vaccine and a similar, rare blood clotting problem connected to the one from Johnson & Johnson which led to a small number of deaths.

There was not enough data on Vaxzevria from Europe to determine if blood clot risks with low blood platelets would differ with each dose of the vaccine, or to provide context on its benefits and risks with regards to gender, the EMA said.

Countries are also in the midst of determining whether to use J&J's vaccine over concerns about blood clots and U.S. regulators were meeting on Friday to consider whether it is safe to resume J&J injections.

Regulators have found these events occurred mostly in the brain and abdomen.

(Reporting by Pushkala Aripaka in Bengaluru, Ludwig Burger in Frankfurt, Alistair Smout and Keith Weir in London; Writing by Josephine Mason; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila, William Maclean)

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚婷婷洲AV久久蜜臀无码 | 国产性色 | 精品国产日韩一区三区 | 国产激情偷乱视频一区二区三区 | 亚洲视频欧美视频 | 四虎在线免费观看 | 欧美精品午夜久久久伊人 | 国产成人手机在线好好热 | 久久亚洲国产精品 | 天天插天天狠天天透 | 免费日韩av | 久久日本精品一区二区三区 | 26uuu中文字幕 | 人人爱国产| 男女做性无遮挡免费视频 | 国产亚洲精品久久久久久国模美 | 一级毛片免费播放 | 92精品国产自产在线观看48页 | 午夜理论电影在线观看亚洲 | 亚洲精品色综合久久 | 三级视频网站 | 亚洲日本中文字幕永久 | 精品av| 九月婷婷开心九月 | 久久久99精品久久久 | 欧美日韩国产手机在线观看视频 | 精品无人乱码一区二区三区 | 日韩五月天 | 中国人免费的片 | 99久久精品费精品国产一区二区 | 久久久久国产亚洲日本 | 欧美福利专区 | 香蕉视频观看 | 免费高清成人啪啪网站 | 亚洲欧洲日本无在线码天堂 | 色综合天天综一个色天天综合网 | 国产成人精品视频播放 | 亚洲成人网在线观看 | 欧美日韩在线视频不卡一区二区三区 | 国产精品久久久久无码人妻精品 | 天天操天天干天天 |